5 drugmakers have recalled metformin products after FDA warning

Since the FDA said in late May that it found unacceptable levels of a caricinogen in metformin — the generic name for a drug commonly used to control blood sugar in Type 2 diabetes patients — five drugmakers have issued recalls of their metformin products. 

Advertisement

The carcinogen, N-nitrosodimethylamine, or NDMA, was originally found by online pharmacy Valisure in early March. 

The five drugmakers that have recalled their metformin products: 

  1. Lupin Pharmaceuticals recalled one lot of its metformin hydrochloride extended-release tablets.
  2. Teva Pharmaceuticals recalled 14 lots of its metformin hydrochloride extended-release tablets, including the 500 mg and 750 mg bottles.
  3. Marksans Pharma Limited recalled one lot of its extended-release metformin tablet.
  4. Amneal Pharmaceuticals recalled all lots of its metformin hydrochloride extended-release tablets.
  5. Apotex recalled all lots of its metformin extended-release tablets. 

More articles on pharmacy:
FDA warns of potential drug interaction with remdesivir
Steroid could reduce COVID-19 deaths: 5 things to know
Walmart buys prescription management tech from CareZone

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.